moclobemide has been researched along with Fibromyalgia in 3 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
Fibromyalgia: A common nonarticular rheumatic syndrome characterized by myalgia and multiple points of focal muscle tenderness to palpation (trigger points). Muscle pain is typically aggravated by inactivity or exposure to cold. This condition is often associated with general symptoms, such as sleep disturbances, fatigue, stiffness, HEADACHES, and occasionally DEPRESSION. There is significant overlap between fibromyalgia and the chronic fatigue syndrome (FATIGUE SYNDROME, CHRONIC). Fibromyalgia may arise as a primary or secondary disease process. It is most frequent in females aged 20 to 50 years. (From Adams et al., Principles of Neurology, 6th ed, p1494-95)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study the usefulness of moclobemide and amitriptyline in the treatment of fibromyalgia (FM) in females without psychiatric disorder." | 9.08 | A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder. ( Hannonen, P; Isomeri, R; Malminiemi, K; Roponen, P; Yli-Kerttula, U, 1998) |
| "To study the usefulness of moclobemide and amitriptyline in the treatment of fibromyalgia (FM) in females without psychiatric disorder." | 5.08 | A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder. ( Hannonen, P; Isomeri, R; Malminiemi, K; Roponen, P; Yli-Kerttula, U, 1998) |
| "Fibromyalgia (FM) syndrome is a chronic condition of unknown aetiology characterised by musculoskeletal pain that often co-exists with sleep disturbance, cognitive dysfunction and fatigue." | 2.48 | Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome. ( Nishishinya, MB; Tort, S; Urrútia, G; Walitt, B, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tort, S | 1 |
| Urrútia, G | 1 |
| Nishishinya, MB | 1 |
| Walitt, B | 1 |
| Zijlstra, TR | 1 |
| van de Laar, MA | 1 |
| Hannonen, P | 1 |
| Malminiemi, K | 1 |
| Yli-Kerttula, U | 1 |
| Isomeri, R | 1 |
| Roponen, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Cannabidiol for Fibromyalgia -The CANNFIB Trial Protocol for a Randomized, Double-blind, Placebo-controlled, Parallel-group, Single-center Trial[NCT04729179] | Phase 3 | 200 participants (Anticipated) | Interventional | 2021-03-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for moclobemide and Fibromyalgia
| Article | Year |
|---|---|
Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome.
Topics: Adult; Carbazoles; Fibromyalgia; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Randomized Contr | 2012 |
1 trial available for moclobemide and Fibromyalgia
| Article | Year |
|---|---|
A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder.
Topics: Adolescent; Adult; Aged; Amitriptyline; Analgesics; Antidepressive Agents, Tricyclic; Benzamides; Di | 1998 |
1 other study available for moclobemide and Fibromyalgia
| Article | Year |
|---|---|
The lack of a placebo effect in a trial of fluoxetine in the treatment of fibromyalgia.
Topics: Amitriptyline; Antidepressive Agents; Antidepressive Agents, Second-Generation; Female; Fibromyalgia | 2002 |